5,281 Cardinal Health, Inc. $CAH Shares Sold by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 22.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,682 shares of the company’s stock after selling 5,281 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in Cardinal Health were worth $4,157,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Downshift Financial LLC increased its holdings in shares of Cardinal Health by 3,666.7% in the 3rd quarter. Downshift Financial LLC now owns 113 shares of the company’s stock worth $25,000 after buying an additional 110 shares during the last quarter. Investors Research Corp purchased a new stake in shares of Cardinal Health during the 2nd quarter valued at $29,000. Maryland Capital Advisors Inc. raised its position in shares of Cardinal Health by 12,600.0% during the 3rd quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock valued at $28,000 after buying an additional 126 shares in the last quarter. Allied Private Wealth LLC bought a new stake in shares of Cardinal Health during the 2nd quarter worth $30,000. Finally, NBH Bank bought a new stake in shares of Cardinal Health during the 2nd quarter worth $31,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $268.10 on Friday. The stock has a market capitalization of $62.08 billion, a P/E ratio of 37.08, a PEG ratio of 1.57 and a beta of 0.53. Cardinal Health, Inc. has a one year low of $180.45 and a one year high of $286.29. The firm’s 50 day simple moving average is $239.73 and its two-hundred day simple moving average is $223.24.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, topping analysts’ consensus estimates of $2.94 by $0.32. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm had revenue of $67.51 billion during the quarter, compared to analyst estimates of $66.67 billion. During the same period in the previous year, the business posted $2.55 EPS. The business’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities analysts expect that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 1st were given a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Adjusted EPS was $3.26, above the roughly $2.94 analyst consensus and up 28% year over year. Revenue rose 5% to $67.5 billion, also topping expectations. Cardinal Health Q1 results and outlook
• Positive Sentiment: Management raised fiscal 2027 adjusted EPS guidance to $12.80–$13.00, signaling confidence in continued growth. Robust pharmaceutical sales helped drive the quarter. Q1 earnings beat on pharmaceutical strength
• Positive Sentiment: Cardinal completed a $500 million share-repurchase program during the quarter. The results also drew favorable analyst attention, including a price-target increase. Analyst raises price target
• Neutral Sentiment: The shares also advanced while the broader market was under pressure, suggesting the earnings and guidance news were a company-specific catalyst. Cardinal gains amid broader market declines
• Negative Sentiment: Management noted modest commodity and petroleum-related pressure in medical distribution, a potential headwind against otherwise healthy demand. Demand and commodity pressures

Wall Street Analysts Forecast Growth

CAH has been the subject of several research reports. Wells Fargo & Company upped their target price on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Barclays raised their price target on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. UBS Group lifted their price target on Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a research note on Friday, October 16th. Morgan Stanley upped their price objective on Cardinal Health from $265.00 to $286.00 and gave the stock an “overweight” rating in a report on Friday, October 30th. Finally, Mizuho set a $290.00 price objective on Cardinal Health in a report on Thursday. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $271.31.

Insiders Place Their Bets

In other news, CEO Deborah Weitzman sold 7,354 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares in the company, valued at approximately $18,341,790.45. The trade was a 8.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jessica L. Mayer sold 29,436 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the transaction, the insider owned 33,076 shares in the company, valued at approximately $7,812,220.44. This represents a 47.09% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 210,271 shares of company stock valued at $49,626,657 over the last three months. 0.12% of the stock is currently owned by company insiders.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.